Search Results - Chrisanthar, R

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Abstract P4-01-02: Low ATM Expression Levels Predict Resistance to Anthracyclins in TP53 and CHK2 Wild-Type Breast Tumors

    Abstract P4-01-02: Low ATM Expression Levels Predict Resistance to Anthracyclins in TP53 and CHK2 Wild-Type Breast Tumors by Knappskog, S, Chrisanthar, R, Løkkevik, E, Anker, G, østenstad, B, Lundgren, S, Risberg, T, Mjaaland, I, Staalesen, V, Miletic, H, Leirvaag, B, Lillehaug, JR, Lønning, PE

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel

    Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel by Chrisanthar, Ranjan, Knappskog, Stian, Løkkevik, Erik, Anker, Gun, Ostenstad, Bjørn, Lundgren, Steinar, Risberg, Terje, Mjaaland, Ingvil, Skjønsberg, Gudbrand, Aas, Turid, Schlichting, Ellen, Fjösne, Hans E, Nysted, Arne, Lillehaug, Johan Richard, Lønning, Per Eystein

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians

    The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians by Knappskog, Stian, Bjørnslett, Merete, Myklebust, Line M., Huijts, Petra E.A., Vreeswijk, Maaike P., Edvardsen, Hege, Guo, Yongli, Zhang, Xuemei, Yang, Ming, Ylisaukko-oja, Sanna K., Alhopuro, Pia, Arola, Johanna, Tollenaar, Rob A.E.M., van Asperen, Christi J., Seynaeve, Caroline, Staalesen, Vidar, Chrisanthar, Ranjan, Løkkevik, Erik, Salvesen, Helga B., Evans, D. Gareth, Newman, William G., Lin, Dongxin, Aaltonen, Lauri A., Børresen-Dale, Anne-Lise, Tell, Grethe S., Stoltenberg, Camilla, Romundstad, Pål, Hveem, Kristian, Lillehaug, Johan R., Vatten, Lars, Devilee, Peter, Dørum, Anne, Lønning, Per E.

    Published in Cancer cell
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel

    Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel by Chrisanthar, Ranjan, Knappskog, Stian, Løkkevik, Erik, Anker, Gun Birgitta, Østenstad, Bjørn, Lundgren, Steinar, Risberg, Terje, Mjaaland, Ingvil, Skjønsberg, Gudbrand, Aas, Turid, Schlichting, Ellen, Fjøsne, Hans Erikssønn, Nysted, Arne, Lillehaug, Johan R, Lønning, Per Eystein

    Request full text
    Article
    Save to List
    Saved in:

Search Tools: